Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 433
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06456138 | Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC | ||
| NCT05834543 | Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma | ||
| NCT06139367 | A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects | ||
| NCT03460457 | Tolerance and Pharmacokinetics of TQB2450 | ||
| NCT05610202 | Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects | ||
| NCT05213767 | Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant Tumors | ||
| NCT06451640 | A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps | ||
| NCT05496569 | TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma | ||
| NCT04373967 | Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes | ||
| NCT06222944 | Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA | ||
| NCT03766490 | Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer | ||
| NCT03890068 | Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma | ||
| NCT06010537 | Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle | ||
| NCT05862337 | Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence. | ||
| NCT05051930 | A Clinical Trial of TQC3721 Suspension for Inhalation | ||
| NCT04768699 | Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia. | ||
| NCT02752516 | A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics | ||
| NCT05476341 | A Phase I Clinical Trial of Bevacizumab Injection | ||
| NCT06429397 | Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma | ||
| NCT06008405 | Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy | ||
| NCT05634473 | A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test | ||
| NCT07037238 | An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations | ||
| NCT02108756 | Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding | ||
| NCT01886053 | A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia | ||
| NCT06851442 | Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer | ||
| NCT03897283 | Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid Tumors | ||
| NCT07314060 | A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis | ||
| NCT06706310 | Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection | ||
| NCT04439890 | A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer | ||
| NCT07110194 | Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies | ||
| NCT06115902 | A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer | ||
| NCT06948539 | To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors | ||
| NCT07011186 | A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies | ||
| NCT02586350 | Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031) | ||
| NCT06552520 | To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis | ||
| NCT04675697 | Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer | ||
| NCT05154630 | Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors | ||
| NCT01874873 | A Phase II Study of Anlotinib in MTC Patients | ||
| NCT06106841 | TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL) | ||
| NCT06230588 | A Clinical Trial of TQH3906 Capsules in Healthy Volunteers | ||
| NCT07501169 | Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC): A Prospective, Single-Arm, Phase II Study(STAR-01) | ||
| NCT04009317 | Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT04569838 | A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection | ||
| NCT05046847 | A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors | ||
| NCT05646758 | A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects | ||
| NCT02029209 | To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT06344351 | A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer | ||
| NCT05068921 | A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy | ||
| NCT07266116 | Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients | ||
| NCT04234607 | A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) |
